The global Recombinant Vaccines Market, valued at USD 9.18 billion in 2022, is projected to experience remarkable growth, with forecasts indicating a surge to USD 21.46 billion by 2030. This growth trajectory represents a robust compound annual growth rate (CAGR) of 11.2% during the forecast period spanning from 2023 to 2030.Recombinant vaccines are a class of vaccines produced using...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek